HumanFirst, a medtech startup that helps companies bring clinical trials and healthcare operations to patients’ homes, has raised $12 million in a Series A round.

The additional capital will go toward increasing the company’s infrastructure layer to support home-focused clinical operations including sensors, in-home visits and testing, said the San Francisco-based company, which was formerly known as Elektra Labs.

“Healthcare is coming home, giving individuals more agency over their health and wellness. We’ve changed our name to reflect this important shift,” said CEO Andy Coravos.

“We need to ensure that home-based operations are as reliable and trustworthy as those within the hospital or the research site. HumanFirst is building the control center to make this happen,” she said.

The round was led by seed investors Maverick Ventures, the venture capital arm of Maverick Capital, joined by Lux Capital, Arkitekt Ventures, Boost VC, SV Angel and Village Global. Threshold Ventures and more than 30 angel investors also joined the group.

This Series A investment brings HumanFirst’s total funding to $15M since its inception in 2017. The company also has received funding from the National Science Foundation and the Harvard Business School Rock Center for Entrepreneurship.

The startup launched its Atlas platform in 2019 to help organizations deploy connected products for clinical trials and remote patient monitoring. Since that time, the company said it has worked with 22 of the top 25 pharmaceutical companies by revenue to evaluate and enable the deployment of technology products.

Maverick Capital also is based in San Francisco.

By Anne Stych Source: https://www.bizjournals.com/bizwomen/news/latest-news/2021/06/startup-that-brings-clinical-trials-to-patients.html